Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Valproate in bipolar disorder: 2000 onwards.

C L Bowden1, V Singh

  • 1Department of Psychiatry, The University of Texas Health Science Center at San Antonio, TX 78229, USA. bowdenc@uthscsa.edu

Acta Psychiatrica Scandinavica. Supplementum
|April 19, 2005
PubMed
Summary

Valproate is an effective treatment for bipolar disorder, particularly mania and mixed episodes. While generally well-tolerated, higher doses may cause side effects, but it remains a key therapy option.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The implications of hypersomnia in the context of major depression: Results from a large, international, observational study.

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology·2019
Same author

Aggressiveness in depression: a neglected symptom possibly associated with bipolarity and mixed features.

Acta psychiatrica Scandinavica·2017
Same author

Integrated transcriptome and methylome analysis in youth at high risk for bipolar disorder: a preliminary analysis.

Translational psychiatry·2017
Same author

Obesity, but not metabolic syndrome, negatively affects outcome in bipolar disorder.

Acta psychiatrica Scandinavica·2015
Same author

Relationships between mixed features and borderline personality disorder in 2811 patients with major depressive episode.

Acta psychiatrica Scandinavica·2015
Same author

Common sources of disparate results and experience in clinical practice vs. results from phase 2 registration studies: lamotrigine as a prototype.

Acta psychiatrica Scandinavica·2015

Area of Science:

  • Neuroscience
  • Pharmacology
  • Psychiatry

Background:

  • Bipolar disorder is a complex mood disorder requiring effective treatment options.
  • Valproate (valproic acid) is a widely used antiepileptic drug with mood-stabilizing properties.

Purpose of the Study:

  • To review the evidence on valproate's efficacy and tolerability in bipolar disorder treatment.
  • To identify factors influencing treatment outcomes with valproate.

Main Methods:

  • Review of studies published from 2000 onwards, emphasizing randomized, prospective clinical trials.
  • Inclusion of published abstracts to broaden the evidence base.

Main Results:

  • Valproate demonstrates efficacy in treating mania, especially mixed mania and irritability.

Related Experiment Videos

  • It is comparable to olanzapine in maintenance therapy and better tolerated.
  • Higher serum levels (>110 microg/ml) correlate with weight gain, sedation, and thrombocytopenia.
  • Potential increased risk of polycystic ovarian syndrome and beneficial effects on cholesterol levels were noted.
  • Combination therapy with antipsychotics shows promise.

    • Conclusions:

    • Valproate is a significant treatment for bipolar disorder, used in monotherapy and combination regimens.
    • Ongoing research aims to further clarify its mechanisms, risks, and benefits.